GA
Gateway Advisory’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $329K | Buy |
2,856
+547
| +24% | +$63K | 0.05% | 112 |
|
|
2024
Q2 | $318K | Buy |
2,309
+15
| +0.7% | +$2.07K | 0.05% | 118 |
|
|
2024
Q1 | $316K | Buy |
2,294
+35
| +2% | +$4.83K | 0.06% | 110 |
|
|
2023
Q4 | $298K | Sell |
2,259
-50
| -2% | -$6.59K | 0.06% | 91 |
|
|
2023
Q3 | $260K | Buy |
+2,309
| New | +$260K | 0.05% | 83 |
|
|
2014
Q1 | – | Sell |
-11,000
| Closed | -$103K | – | 48 |
|
|
2013
Q4 | $103K | Buy |
+11,000
| New | +$103K | 0.06% | 40 |
|